Study Quantifies Risk for Gastric, Breast Cancer for Germline CDH1 P/LP Variants
By Elana Gotkine HealthDay Reporter
FRIDAY, June 21, 2024 -- The cumulative risk for advanced gastric cancer varies from 6.5 to 10.3 percent for carriers of germline CDH1 pathogenic/likely pathogenic (P/LP) variants, according to a study published online June 14 in the Journal of the American Medical Association to coincide with presentation at the International Gastric Cancer Linkage Consortium, held from June 13 to 15 in Porto, Portugal.
Carrie E. Ryan, M.D., from the National Institutes of Health in Bethesda, Maryland, and colleagues describe gastric and breast cancer risk estimates for individuals with CDH1 variants in a multicenter retrospective cohort and modeling study. Data were included from 213 families from North America with a germline CDH1 P/LP variant; 883 of the 7,323 individuals had a CDH1 P/LP variant.
The researchers found that the prevalence of gastric cancer was 13.9 percent among those with a CDH1 P/LP variant, and the prevalence of breast cancer was 26.3 percent among female carriers. The estimated hazard ratio for advanced gastric cancer was 33.5 and 3.5 at ages 30 and 70 years, respectively. In male and female carriers, the lifetime cumulative risk for advanced gastric cancer was 10.3 and 6.5 percent, respectively. A carrier with three affected first-degree relatives had a penetrance of about 38 percent in gastric cancer risk estimates based on family history. The hazard ratio for breast cancer among female carriers was 5.7 and 3.9 at ages 30 and 70 years, respectively; the lifetime cumulative risk for breast cancer was 36.8 percent among female carriers.
"These findings inform current management of individuals with germline CDH1 variants," the authors write.
Two authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2024
Read this next
Disparities Seen in Biennial Mammography Screening for Women in in Their 40s
MONDAY, Dec. 23, 2024 -- For women aged 40 to 49 years, there are considerable disparities and gaps in biennial mammography screening, according to a research letter published...
Cannabidiol Safe, May Lower Anxiety in Advanced Breast Cancer
FRIDAY, Dec. 20, 2024 -- For patients with advanced breast cancer and baseline clinical anxiety, cannabidiol (CBD) is safe and may reduce anxiety levels two to four hours after...
Breast Cancer Risk Increased With Weight Gain After Age 35 Years
WEDNESDAY, Dec. 18, 2024 -- The risk for breast cancer is increased with weight gain after age 35 years, according to a research letter recently published in Cancer Biology &...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.